Literature DB >> 12793027

[Vaccination against Alzheimer disease?].

Imrich Blasko, Beatrix Grubeck-Loebenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12793027     DOI： 10.1007/bf03040332

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  9 in total

Review 1.  [Dementia--the price for increased life expectancy?].

Authors:  S Weyerer
Journal:  Wien Klin Wochenschr       Date:  2001-03-15       Impact factor: 1.704

2.  Immunization with beta-amyloid: could T-cell activation have a harmful effect?

Authors:  B Grubeck-Loebenstein; I Blasko; F K Marx; I Trieb
Journal:  Trends Neurosci       Date:  2000-03       Impact factor: 13.837

3.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 4.  Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

Authors:  Dale Schenk
Journal:  Nat Rev Neurosci       Date:  2002-10       Impact factor: 34.870

5.  Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

Authors:  Christoph Hock; Uwe Konietzko; Andreas Papassotiropoulos; Axel Wollmer; Johannes Streffer; Ruth C von Rotz; Gabriela Davey; Eva Moritz; Roger M Nitsch
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

6.  [Etiology and pathogenesis of Alzheimer dementia].

Authors:  T Kratzsch; J Peters; L Frölich
Journal:  Wien Med Wochenschr       Date:  2002

7.  Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

Authors:  James A R Nicoll; David Wilkinson; Clive Holmes; Phil Steart; Hannah Markham; Roy O Weller
Journal:  Nat Med       Date:  2003-03-17       Impact factor: 53.440

Review 8.  Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Authors:  Imrich Blasko; Beatrix Grubeck-Loebenstein
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease.

Authors:  K Trieb; G Ransmayr; R Sgonc; H Lassmann; B Grubeck-Loebenstein
Journal:  Neurobiol Aging       Date:  1996 Jul-Aug       Impact factor: 4.673
  9 in total
  3 in total

1.  New health care challenges for the "old Europe".

Authors:  Jean-Pierre Michel
Journal:  Wien Klin Wochenschr       Date:  2003-05-15       Impact factor: 1.704

Review 2.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-06-01

Review 3.  Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Am J Neurodegener Dis       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.